Medable

02/27/2026

Let’s ask a trick question. Do you think your organization’s data is ready for AI or AI agents?

In a landscape defined by speed, complexity, and constant change, progress doesn’t come from waiting for ideal conditions. It comes from taking the first step. And with agentic AI, you can start now.

Learn more here: https://www.medable.com/knowledge-center/blog-compounding-interest-why-good-enough-data-is-good-enough-for-agentic-ai
________

Agentic AI doesn’t require perfect clinical trial data. Learn why “good enough” data can already drive real impact for sponsors and CROs.

02/24/2026

Assessment and instrument translations can bring global study deployment to a grinding halt. 🫠

Back-and-forth files. Version confusion. Validation headaches.
It doesn't have to be this way.

Rana Khan demos below how we built localization into eCOA the right way.
________

02/20/2026

If your eCOA RFI is just a feature checklist, you’re setting yourself up for problems later.
“Do you support X?” is easy to answer. “Prove your uptime, implementation track record, and audit history” is harder.

The difference shows up mid-study, when switching vendors isn’t an option.

Here’s how to write an RFI that protects you before you sign: https://www.medable.com/knowledge-center/blog-ecoa-standards-and-kpis-to-include-in-your-next-rfi
_________

Strengthen your next eCOA RFI with performance-driven standards and measurable KPIs and to evaluate vendors based on outcomes instead of promises.

02/18/2026

Most “AI in clinical trials” is just analysis after the fact. What if it could actually move the work forward?

Agents that understand messy data. Agents that unify it across systems. Agents that take action.

That’s what Medable’s Agent Studio is built for. Fiachra Matthews breaks it down below.
________

02/17/2026

Your leadership wants AI-powered workflows, but your teams are already overloaded, and the wrong decision will cost you time and budget that you don't have.

Tomorrow’s virtual event gets straight at what’s working in clinical operations. You'll hear from experts actually implementing the tools at Novo Nordisk and Boehringer Ingelheim and get advice based on real-life experience.

Practical. Unfiltered. No fluff.

Register now to secure your spot: https://event.on24.com/wcc/r/5210264/43998D4882BFF1C796ACBFC495815F4A
________

02/16/2026

The uncomfortable truth? A classic study using paper COAs showed 90% reported compliance… but only 11% actual compliance.

That’s not data collection. That’s data fiction.

In 2026, paper assessments are no longer the conservative option. They're a liability.

Learn more here: https://www.medable.com/knowledge-center/blog-paper-coas-in-2026-its-not-cheaper-its-riskier
________

Paper COAs may seem simple, but in 2026 they create regulatory, compliance, safety, and data integrity risks. Discover why eCOA systems are becoming the standard for inspection-ready clinical trials.

02/13/2026

"Instead of researchers manually generating hypotheses, designing studies, reviewing data, and coordinating decisions, agentic systems will autonomously propose targets, run virtual experiments, optimize protocols, monitor safety signals, and surface recommendations." - Andrew Mackinnon, Medable.

Hear more from 14 industry leaders about what AI excellence looks like for life sciences in 2026 and beyond: https://insights.citeline.com/scrip/scrip-asks/scrip-asks-what-does-2026-hold-for-biopharma-part-5-ai-and-operational-excellence-5LNE27W3KREGPC64NNRZLGQ5CU/
________

About 50 pharmaceutical industry leaders surveyed by Scrip predict 2026 will mark AI's shift from pilot programs to committed operational deployment. However, competitive advantage will depend on organizational transformation and digital infrastructure maturity, not algorithmic sophistication alone.

02/12/2026

Lengthy, manual assessment builds. Endless review cycles. Avoidable errors. All GONE. ✅ ✅

In this demo clip, Rana Khan shows how Medable’s AI-powered Study Studio compresses eCOA build timelines from weeks to minutes—while baking quality into the study as it’s created, not patched in later.
________

02/11/2026

When caregivers are overlooked in clinical trials, protocol adherence slips and the overall experience suffers.

Medable builds caregiver engagement directly into your studies, ensuring communication is clear, responsibilities are defined, and nothing falls through the cracks.

Watch RJ Lozano’s demo below to see how our caregiver capabilities enhance patient retention and improve data quality from day one.
________

02/10/2026

“Agentic AI changes the dynamic for sponsors and sites by providing the support needed to manage large volumes of clinical data, allowing investigators to focus on review, judgment, and sign-off rather than manual reconciliation.” - Erika Motley, Director of Product at Medable.

Learn more about our PI Summary Agent here: https://www.bioxconomy.com/clinical-and-research/medable-launches-ai-agent-to-streamline-clinical-trial-data-assessment-for-principal-investigators
________

Medable's new AI agent helps principal investigators streamline clinical trial data assessment and reduce site workload burden

02/06/2026

In this special feature, leading drug developers, device manufacturers, and contract organizations dispel the myths around AI and machine learning in the pharma industry. They share how they're using AI to streamline clinical trials, optimize resource allocation, and improve patient-friendly dosage forms.

Learn more from the experts, including Medable's Andrew Mackinnon, here: https://drug-dev.com/special-feature-artificial-intelligence-in-drug-discovery-development-delivery/
________

Contributor Cindy H. Dubin speaks with leading drug makers, device manufacturers, and contract organizations who dispel the myths around AI and Machine Learning in the pharma industry and share how they are using AI to streamline clinical trials, automate lab tests, optimize resource allocation, enh...

02/03/2026

It's been non-stop for Team Medable at so far! Stop by booth #806 if you're curious about 'big TMF energy' 😜.

Our AI agents enable highly skilled professionals to perform more strategic work so they can truly move the needle on clinical development.

We'll show you how!
________